av/eris-lifesciences--big.svg

IN:CO:ERIS

Eris

  • Stock

Last Close

1,374.20

25/11 09:40

Market Cap

141.09B

Beta: -

Volume Today

426.46K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
440.05M
-
512.08M
16.37%
526.13M
2.74%
517.21M
1.70%
606.34M
17.23%
740.50M
22.13%
760.64M
2.72%
819.71M
7.77%
1.06B
29.54%
1.25B
17.41%
average payables
297M
-
370.47M
24.74%
183.56M
50.45%
192.59M
4.92%
192.59M
0%
420.63M
118.41%
920.88M
118.93%
1.01B
10.04%
1.10B
8.74%
1.21B
10.05%
average receivables
186.69M
-
488.69M
161.76%
945.75M
93.53%
1.52B
61.14%
880.18M
42.24%
1.14B
29.55%
2.27B
99.14%
2.61B
15.11%
book value per share
12.84
-
19.32
50.52%
23.33
20.77%
39.27
68.28%
62.64
59.52%
83.66
33.56%
94.49
12.95%
116.10
22.87%
140.45
20.97%
161.47
14.97%
capex per share
-3.78
-
-0.95
74.81%
-1.72
80.69%
-3.62
110.43%
-1.83
49.55%
-2.76
51.40%
-11.03
299.05%
-1.90
82.79%
-8.91
369.47%
-61.87
594.55%
capex to depreciation
-10.89
-
-0.84
92.26%
-1.16
37.71%
-2.10
80.44%
-0.98
53.30%
-1.05
6.81%
-3.01
187.96%
-0.60
80.09%
-1.87
212.09%
-7.19
284.18%
capex to operating cash flow
-0.58
-
-0.15
74.93%
-0.18
23.76%
-0.25
38.43%
-0.11
57.03%
-0.17
59.33%
-0.56
227.44%
-0.07
87.70%
-0.32
366.19%
-2.88
801.39%
capex to revenue
-0.10
-
-0.02
76.50%
-0.04
65.11%
-0.07
73.29%
-0.03
57.26%
-0.04
33.95%
-0.14
263.86%
-0.02
84.89%
-0.09
322.49%
-0.51
454.79%
cash per share
5.40
-
5.45
0.96%
5.40
1.03%
18.97
251.68%
7.59
59.99%
23.45
208.82%
10.35
55.86%
3.85
62.81%
13.04
238.86%
6.56
49.70%
days of inventory on hand
162.97
-
218.62
34.15%
172.79
20.96%
190.77
10.40%
175.36
8.07%
194.45
10.89%
141.88
27.04%
142.56
0.48%
165.02
15.76%
136.15
17.49%
days payables outstanding
135.95
-
139.33
2.48%
131.63
-
197.92
-
204.32
3.23%
154.86
24.21%
164.83
6.44%
129.25
21.58%
days sales outstanding
22.83
-
30.41
33.21%
54.93
80.62%
66.43
20.95%
69.80
-
62.23
10.84%
65.17
4.72%
debt to assets
0.03
-
0.01
67.97%
0.00
87.28%
0.01
913.34%
0.26
2,031.97%
0.11
56.00%
0.01
93.11%
0.00
52.78%
0.04
905.75%
0.24
543.52%
debt to equity
0.04
-
0.01
71.90%
0.00
87.66%
0.01
822.13%
0.44
2,944.24%
0.15
64.95%
0.01
93.89%
0.00
54.11%
0.04
928.88%
0.40
802.60%
dividend yield
0.01
-
0.00
79.64%
0.01
-
0.01
2.07%
0.01
4.05%
0.01
47.22%
earnings yield
0.01
-
0.01
26.72%
0.02
49.68%
0.03
81.24%
0.03
8.75%
0.03
24.44%
0.06
76.28%
0.04
26.21%
0.04
0.39%
0.05
13.18%
enterprise value
82.71B
-
82.68B
0.04%
82.62B
0.07%
82.76B
0.17%
113.78B
37.48%
89.19B
21.61%
50.06B
43.87%
81.85B
63.50%
93.91B
14.74%
86.01B
8.41%
enterprise value over ebitda
83.38
-
67.97
18.48%
48.02
29.36%
30.64
36.19%
35.08
14.49%
25.48
27.36%
13.21
48.15%
18.84
42.63%
18.90
0.31%
15.70
16.95%
ev to operating cash flow
92.29
-
91.81
0.52%
62.84
31.55%
41.41
34.11%
48.49
17.11%
39.99
17.52%
18.46
53.83%
21.80
18.09%
24.83
13.86%
29.48
18.75%
ev to sales
16.26
-
15.16
6.77%
13.84
8.69%
11.42
17.51%
13.30
16.49%
9.22
30.66%
4.73
48.70%
6.86
45.07%
7.08
3.19%
5.18
26.91%
free cash flow per share
2.74
-
5.60
104.22%
7.84
40.10%
10.92
39.21%
15.24
39.58%
13.45
11.73%
8.73
35.07%
25.75
194.77%
18.93
26.47%
-40.42
313.49%
free cash flow yield
0.00
-
0.01
104.22%
0.01
40.10%
0.02
39.21%
0.02
4.84%
0.02
11.11%
0.02
11.99%
0.04
79.74%
0.03
35.41%
-0.07
357.01%
graham net net
0.50
-
1.17
132.39%
2.29
95.84%
16.95
640.54%
-24.76
246.08%
8.07
132.59%
-5.78
171.59%
0.90
115.54%
3.08
242.90%
-78.62
2,653.60%
graham number
38.46
-
53.12
38.11%
71.41
34.45%
124.72
74.64%
173.63
39.21%
199.51
14.91%
214.36
7.44%
261.39
21.94%
307.33
17.58%
319.51
3.96%
income quality
0.91
-
0.82
9.70%
0.85
3.43%
0.76
10.99%
0.75
0.82%
0.70
6.50%
0.82
16.44%
0.95
16.29%
0.86
10.10%
0.72
15.72%
intangibles to total assets
0.01
-
0.01
17.05%
0.00
86.02%
0.18
10,761.12%
0.56
208.37%
0.46
18.15%
0.51
12.08%
0.42
16.93%
0.33
21.79%
0.60
82.02%
interest coverage
383.22
-
5.89K
1,436.28%
1.28K
78.18%
1.01K
21.01%
28.10
97.23%
13.58
51.67%
152.00
1,019.16%
217.17
42.87%
104.23
52.01%
16.46
84.20%
interest debt per share
0.60
-
0.25
58.76%
0.05
81.62%
0.58
1,190.48%
28.17
4,741.26%
14.49
48.55%
1.04
92.81%
0.63
39.41%
6.52
931.50%
66.39
918.65%
inventory turnover
2.24
-
1.67
25.46%
2.11
26.52%
1.91
9.42%
2.08
8.78%
1.88
9.82%
2.57
37.06%
2.56
0.48%
2.21
13.61%
2.68
21.20%
invested capital
0.04
-
0.01
71.90%
0.00
87.66%
0.01
822.13%
0.44
2,944.24%
0.15
64.95%
0.01
93.89%
0.00
54.11%
0.04
928.88%
0.40
802.60%
market cap
82.71B
-
82.71B
0%
82.71B
0%
82.71B
0%
110.12B
33.14%
87.50B
20.54%
50.61B
42.16%
82.15B
62.32%
93.58B
13.91%
77.81B
16.85%
net current asset value
657.38M
-
757.83M
15.28%
647.56M
14.55%
2.83B
337.65%
-2.75B
197.18%
1.97B
171.51%
2.24B
13.56%
2.09B
6.69%
2.63B
26.21%
-6.82B
358.90%
net debt to ebitda
0.01
-
-0.02
396.26%
-0.05
150.14%
0.02
140.64%
1.13
5,612.97%
0.48
57.25%
-0.15
130.11%
-0.07
52.33%
0.07
197.65%
1.50
2,114.00%
net income per share
5.12
-
6.49
26.72%
9.71
49.68%
17.61
81.24%
21.39
21.49%
21.15
1.14%
21.61
2.21%
26.16
21.02%
29.89
14.28%
28.10
5.99%
operating cash flow per share
6.52
-
6.55
0.48%
9.56
46.00%
14.54
52.01%
17.06
17.40%
16.22
4.97%
19.76
21.87%
27.64
39.89%
27.84
0.70%
21.45
22.95%
payables turnover
2.68
-
2.62
2.42%
2.77
-
1.84
-
1.79
3.13%
2.36
31.94%
2.21
6.05%
2.82
27.53%
receivables turnover
15.99
-
12.00
24.93%
6.65
44.63%
5.49
17.32%
5.23
-
5.87
12.16%
5.60
4.51%
research and ddevelopement to revenue
0.00
-
0.00
369.97%
0.00
6.73%
0.00
7.67%
0.02
478.20%
0.00
85.13%
return on tangible assets
0.26
-
0.25
4.26%
0.32
26.46%
0.46
44.15%
0.45
1.51%
0.34
24.29%
0.39
13.51%
0.34
13.86%
0.27
20.41%
0.26
1.75%
revenue per share
37.01
-
39.68
7.22%
43.42
9.43%
52.72
21.43%
62.23
18.02%
70.33
13.03%
77.13
9.67%
87.84
13.87%
97.60
11.12%
122.19
25.19%
roe
0.40
-
0.34
15.81%
0.42
23.94%
0.45
7.70%
0.34
23.84%
0.25
25.98%
0.23
9.51%
0.23
1.50%
0.21
5.53%
0.17
18.23%
roic
0.37
-
0.32
12.36%
0.42
30.34%
0.41
1.83%
0.23
44.98%
0.21
4.97%
0.22
3.58%
0.22
0.50%
0.20
11.93%
0.13
34.56%
sales general and administrative to revenue
0.06
-
0.07
6.11%
0.06
16.24%
0.05
10.03%
0.04
21.76%
0.03
16.12%
0.03
1.53%
0.04
8.20%
0.04
5.34%
0.03
25.32%
shareholders equity per share
12.84
-
19.32
50.52%
23.33
20.77%
39.27
68.28%
62.64
59.52%
83.66
33.56%
94.49
12.95%
116.10
22.87%
140.45
20.97%
161.47
14.97%
stock based compensation to revenue
0.00
-
0.00
8.10%
0.00
40.17%
0.00
8.80%
0.00
83.81%
tangible asset value
1.77B
-
2.65B
49.93%
3.23B
21.86%
4.24B
31.23%
740.17M
82.56%
4.62B
523.68%
5.04B
9.26%
7.99B
58.38%
11.55B
44.60%
82.32M
99.29%
tangible book value per share
12.87
-
19.30
49.93%
23.52
21.86%
30.86
31.23%
5.38
82.56%
33.57
523.59%
36.77
9.53%
58.84
60.02%
85.02
44.50%
0.61
99.29%
working capital
838.32M
-
976.07M
16.43%
903.39M
7.45%
3.09B
241.67%
732.47M
76.27%
2.76B
277.14%
3.15B
14.00%
3.00B
4.70%
4.28B
42.51%
3.21B
24.83%

All numbers in (except ratios and percentages)